1715Labs
A company being established to commercialise Zooniverse technology
Incorporated in July 2018
Origin: Oxford University, Department of Physics
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
A company being established to commercialise Zooniverse technology
Incorporated in July 2018
Origin: Oxford University, Department of Physics
AR/AV platform technology for software industry. 6D.ai was aquired by Niantic in March 2020.
Incorporated in October 2017
Origin: Oxford University, Department of Engineering Science
Developing immunotherapies that can potentially transform cancer treatment.
Incorporated in December 2007
Origin: Oxford University
A B2B tech platform for clothing retailers to make fit & style accessible to more people, leveraging computer vision, and deep learning. AISTETIC is aiming to reduce online returns and increase conversion for retailers.
Origin: Oxford University, Department of Computer Science
Contact: Sandeep Singh
The advancement, through pre-clinical and clinical trials, the development a number of lentiviral-based gene therapies for respiratory diseases.
Incorporated in July 2023
Origin: Oxford University, Nuffield Department of Clinical Laboratory Sciences
Animal Dynamics marries fine-engineering skills with a deep understanding of the fundamental mechanisms, to produce revolutionary machines that will change the shape of the future, taking inspiration from our environment in order to protect it, and capable of performance beyond anything currently found in nature or engineering.
Incorporated in April 2015
Origin: Oxford University, Department of Zoology
The development of cancer drugs that reprogram cancer cells to undergo the body's natural process of cell death.
Incorporated in April 2016
Origin: Oxford University, Sir William Dunn School of Pharmacology
To develop compound libraries based on the asymmetric synthesis methodolofies.
Incorporated in March 2019
Origin: Oxford University, Department of Chemistry
Aurox was established to research, develop, manufacture and commercially exploit products in the field of confocal microscopy and automated pathology slide scanners.
Incorporated in July 2006
Origin: Oxford University, Department of Engineering Science
Breath analysis.
Incorporated in June 2004
Origin: Oxford University, Physical and Theoretical Chemistry
Specialising in biotechnology. In 2006 Avidex was acquired by Medigene AG.
Incorporated in March 1999
Origin: Oxford University
DNA methylation detection using this TAPS technology. Base Genomics was acquired by Exact Sciences in October 2020.
Incorporated in June 2020
Origin: Oxford University, Ludwig Institute for Cancer Research